Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Depigmented Mite Allergen Extracts in Allergic Rhinitis with Asthma
NCT02340130Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Sep 2014
- Primary completion
- May 2018
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of DP/MG/14-1, DP/MG/14-2 in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by LETI Pharma. Started Sep 2014; status: completed.
02
Drugs
DP/MG/14-1DP/MG/14-2
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT02340130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340130.